S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:SMFR

Sema4 Stock Forecast, Price & News

$4.04
+0.01 (+0.25%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.87
$4.11
50-Day Range
$4.03
$8.05
52-Week Range
$3.87
$27.18
Volume
999,827 shs
Average Volume
1.57 million shs
Market Capitalization
$974.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SMFR News and Ratings via Email

Sign-up to receive the latest news and ratings for Sema4 and its competitors with MarketBeat's FREE daily newsletter.


Sema4 logo

About Sema4

Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 Holdings Corp, formerly known as CM Life Sciences, is based in STAMFORD, Conn.

Headlines

Sema4 (NASDAQ:SMFR) Sets New 12-Month Low at $3.91
January 14, 2022 |  americanbankingnews.com
Sema4 (NASDAQ:SMFR) Shares Down 4.9%
January 11, 2022 |  americanbankingnews.com
Sema4 (NASDAQ:SMFR) Shares Gap Up to $4.11
January 10, 2022 |  americanbankingnews.com
Sema4 (NASDAQ:SMFR) Reaches New 52-Week Low at $4.34
December 28, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMFR
Fax
N/A
Employees
3
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.09 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$974.69 million
Optionable
Optionable

Company Calendar

Last Earnings
11/15/2021
Today
1/18/2022
Next Earnings (Estimated)
2/21/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.99 out of 5 stars

Medical Sector

622nd out of 1,417 stocks

Health Services Industry

7th out of 17 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












Sema4 (NASDAQ:SMFR) Frequently Asked Questions

Is Sema4 a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sema4 in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sema4 stock.
View analyst ratings for Sema4
or view top-rated stocks.

When is Sema4's next earnings date?

Sema4 is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022.
View our earnings forecast for Sema4
.

How were Sema4's earnings last quarter?

Sema4 Holdings Corp (NASDAQ:SMFR) released its quarterly earnings data on Monday, November, 15th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.19) by $0.34. The firm earned $43.18 million during the quarter, compared to the consensus estimate of $42 million.
View Sema4's earnings history
.

What guidance has Sema4 issued on next quarter's earnings?

Sema4 updated its FY 2021 earnings guidance on Monday, December, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $201 million-$204 million, compared to the consensus revenue estimate of $200.99 million.

What price target have analysts set for SMFR?

4 equities research analysts have issued 1-year price targets for Sema4's shares. Their forecasts range from $12.00 to $13.00. On average, they expect Sema4's stock price to reach $12.50 in the next year. This suggests a possible upside of 209.4% from the stock's current price.
View analysts' price targets for Sema4
or view top-rated stocks among Wall Street analysts.

What is Sema4's stock symbol?

Sema4 trades on the NASDAQ under the ticker symbol "SMFR."

How do I buy shares of Sema4?

Shares of SMFR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sema4's stock price today?

One share of SMFR stock can currently be purchased for approximately $4.04.

How much money does Sema4 make?

Sema4 has a market capitalization of $974.69 million.

How many employees does Sema4 have?

Sema4 employs 3 workers across the globe.

What is Sema4's official website?

The official website for Sema4 is cmlifesciencesspac.com.

Where are Sema4's headquarters?

Sema4 is headquartered at 667 Madison Avenue, New York NY, 10065.

How can I contact Sema4?

Sema4's mailing address is 667 Madison Avenue, New York NY, 10065. The company can be reached via phone at 800-298-6470 or via email at [email protected].


This page was last updated on 1/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.